For instance, the detection of EGFR mutations in cell-free DNA in the blood (the so-called “liquid biopsy”) of a patient with a lung tumor is meanwhile almost equivalent to the diagnosis of a lung adenocarcinoma, as specific activating EGFR mutations are almost exclusively found in these tumor types [56]. The gene discussed is EGFR; the disease is neoplasm.